C12Y 601/01007
Alanine--trna ligase
Official title: Alanine--tRNA ligase (6.1.1.7)
C12Y601/01007 (Alanine--trna ligase) appears on 6 US grants and 12 published applications in this corpus.
Search patents in C12Y- Granted patents
- 6
- Published applications
- 12
- Assignees
- 8
- Inventors
- 19
- Latest grant
- 30 Dec 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2013 | 0 | 2 |
| 2014 | 0 | 0 |
| 2015 | 3 | 3 |
| 2016 | 2 | 0 |
| 2017 | 0 | 2 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 1 |
| 2021 | 0 | 0 |
| 2022 | 0 | 1 |
| 2023 | 0 | 0 |
| 2024 | 0 | 1 |
| 2025 | 1 | 0 |
| 2026 | 0 | 2 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Aminoacyl-tRNA synthetases and uses hereof30 Dec 2025US 12,509,675 B2Novo Nordisk A/S
- Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of alanyl tRNA synthetases26 Apr 2016US 9,320,782 B2aTyr Pharma, Inc.
- Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of Lysyl-tRNA synthetases26 Apr 2016US 9,322,009 B2aTyr Pharma, Inc.
- Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of alanyl-tRNA synthetases31 Mar 2015US 8,993,723 B2aTyr Pharma, Inc.
- Composition, method and kit for obtaining purified recombinant proteins17 Mar 2015US 8,981,067 B2New England Biolabs, Inc.
- Method for genetically encoding 2-aminoisobutyric acid and its analogs and applications thereof8 Oct 2026US 2026/0308223 A1Edipro Pharmaceutical Technology Inc.
- Aminoacyl-trna synthetases and uses hereof23 Jul 2026US 2026/0209742 A1Novo Nordisk A/S
- Methods for Producing Recombinant Proteins2 May 2024US 2024/0141403 A1The Regents of the University of California
- Aminoacyl-trna synthetases and uses hereof11 Aug 2022US 2022/0251535 A1Novo Nordisk A/S
- Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of alanyl trna synthetases16 Jul 2020US 2020/0223942 A1aTyr Pharma, Inc.
Most cited
By later US patents
- Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of Lysyl-tRNA synthetases8US 8,962,560 B2aTyr Pharma, Inc. · 2015
- Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of alanyl-tRNA synthetases7US 8,993,723 B2aTyr Pharma, Inc. · 2015
- Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of alanyl tRNA synthetases2US 9,320,782 B2aTyr Pharma, Inc. · 2016
- Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of Lysyl-tRNA synthetases1US 9,322,009 B2aTyr Pharma, Inc. · 2016